Skip to main content

Akebia Therapeutics, Inc.

AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001517022

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Akebia Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
−10 vs. Q2 2021
Shares held
98.5M
−7.56M (−7.1%) vs. Q2 2021
Total value
$283.7M
−$118.3M (−29.4%) vs. Q2 2021
New holders
12
49 more added
Sold out
22
36 more reduced

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 127 institutions
Q1 2021: 145 institutionsQ2 2021: 139 institutionsQ3 2021: 127 institutionsQ4 2021: 133 institutionsQ1 2022: 124 institutionsQ2 2022: 97 institutionsQ3 2022: 90 institutionsQ4 2022: 75 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 76 institutionsQ4 2023: 87 institutionsQ1 2024: 114 institutionsQ2 2024: 103 institutionsQ3 2024: 114 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 158 institutionsQ3 2025: 177 institutionsQ4 2025: 166 institutionsQ1 2026: 171 institutionsQ2 2026: 170 institutions
Value heldQ3 2021: $283.7M
Q1 2021: $340.3MQ2 2021: $402.4MQ3 2021: $283.7MQ4 2021: $218.7MQ1 2022: $58.3MQ2 2022: $20.2MQ3 2022: $16.5MQ4 2022: $30.2MQ1 2023: $29.1MQ2 2023: $46.0MQ3 2023: $58.0MQ4 2023: $72.7MQ1 2024: $104.3MQ2 2024: $57.4MQ3 2024: $78.4MQ4 2024: $128.9MQ1 2025: $182.7MQ2 2025: $394.1MQ3 2025: $337.7MQ4 2025: $190.4MQ1 2026: $141.4MQ2 2026: $123.2M
Institutions holding AKBA and their total value by quarter
QuarterHoldersValue
Q2 2026170$123.2M
Q1 2026171$141.4M
Q4 2025166$190.4M
Q3 2025177$337.7M
Q2 2025158$394.1M
Q1 2025143$182.7M
Q4 2024121$128.9M
Q3 2024114$78.4M
Q2 2024103$57.4M
Q1 2024114$104.3M
Q4 202387$72.7M
Q3 202376$58.0M
Q2 202379$46.0M
Q1 202365$29.1M
Q4 202275$30.2M
Q3 202290$16.5M
Q2 202297$20.2M
Q1 2022124$58.3M
Q4 2021133$218.7M
Q3 2021127$283.7M
Q2 2021139$402.4M
Q1 2021145$340.3M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding AKBA in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Sonora Investment Management, LLC13,100$38.0K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.11,500$33.0K0.00%00.0%Unchanged
Kingsview Wealth Management, LLC10,959$32.0K0.00%−3,445−23.9%Reduced
AE Wealth Management LLC10,300$30.0K0.00%00.0%Unchanged
Great West Life Assurance Co7,428$21.0K0.00%00.0%Unchanged
Penserra Capital Management LLC3,995$11.0K0.00%+350+9.6%Added
O'Shaughnessy Asset Management, LLC3,379$10.0K0.00%−11,314−77.0%Reduced
Fifth Third Bancorp3,300$10.0K0.00%00.0%Unchanged
Macquarie Group Ltd3,370$10.0K0.00%00.0%Unchanged
Signaturefd, LLC2,203$6.00K0.00%+678+44.5%Added
Rockefeller Capital Management L.P.1,871$5.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.963$3.00K0.00%−12,093−92.6%Reduced
Truvestments Capital LLC900$3.00K0.00%00.0%Unchanged
Baldwin Brothers Inc561$2.00K0.00%00.0%Unchanged
Cutler Group LP700$2.00K0.00%00.0%Unchanged
Ellevest, Inc.757$2.00K0.00%+104+15.9%Added
Exane Derivatives471$1.36K0.00%00.0%Unchanged
Daiwa Securities Group Inc.316$1.00K0.00%00.0%Unchanged
Hexagon Capital Partners LLC186$1.00K0.00%00.0%Unchanged
IFP Advisors, Inc152$1.00K0.00%+50+49.0%Added
Federation des caisses Desjardins du Quebec150$4320.00%00.0%Unchanged
Captrust Financial Advisors10$00.00%−357−97.3%Reduced
Focused Wealth Management, Inc65$00.00%00.0%Unchanged
FMR LLC37$00.00%+37New
First Horizon Advisors, Inc.63$00.00%+63New
Gerber Kawasaki Wealth & Investment Management50$00.00%+50New
Meridian Wealth Partners, LLC266$00.00%+266New
Wellington Management Group LLP0$00.00%−10,736,859−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−267,603−100.0%Sold out
Millennium Management LLC0$00.00%−264,954−100.0%Sold out
HRT Financial LP0$00.00%−62,446−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−51,044−100.0%Sold out
Virtu Financial LLC0$00.00%−46,270−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−41,781−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−41,564−100.0%Sold out
XTX Topco Ltd0$00.00%−20,589−100.0%Sold out
Gotham Asset Management, LLC0$00.00%−19,195−100.0%Sold out
Quantitative Systematic Strategies LLC0$00.00%−18,732−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−18,451−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−17,189−100.0%Sold out
Acadian Asset Management LLC0$00.00%−10,636−100.0%Sold out
Pinz Capital Management, LP0$00.00%−6,300−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−947−100.0%Sold out
Magnus Financial Group LLC0$00.00%−1,000−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−843−100.0%Sold out
US Bancorp0$00.00%−309−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−207−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−383−100.0%Sold out
Toronto Dominion Bank0$00.00%−22−100.0%Sold out
QS Investors, LLC––––Not filed
First Horizon Corp––––Not filed